2C-I
2C-I is a psychedelic phenethylamine from Alexander Shulgin's 2C family, closely related to 2C-B and 2C-E. It produces its effects by activating serotonin 5-HT2A receptors. It is milder and shorter than 2C-E, but should not be confused with the far more dangerous NBOMe compound sold as "Smiles."
Overview
2C-I (2,5-dimethoxy-4-iodophenethylamine) is a synthetic psychedelic of the phenethylamine class and a member of the "2C" family first synthesized and described by the chemist Alexander Shulgin, who reported it in 1977 and later in his 1991 book PiHKAL. It is a close relative of 2C-B and 2C-E, differing in the chemical group at one position on the molecule (in this case iodine). It is usually taken orally as a powder or in capsules and is used recreationally as a "new psychoactive substance." Importantly, 2C-I is sometimes confused with 25I-NBOMe (nicknamed "Smiles" or "N-bomb"), a chemically different and considerably more dangerous drug — the two are not the same.
Source: Shulgin (PiHKAL); peer-reviewed pharmacology literature
Chemistry & mechanism of action
Like the other 2C compounds and classic psychedelics such as 2C-B and LSD, 2C-I produces its psychedelic effects mainly by activating serotonin 5-HT2A receptors in the brain, acting as a partial agonist at the 5-HT2 receptor family. Unlike stimulant-type phenethylamines, it is essentially inactive as a monoamine releaser and has negligible reuptake-inhibiting activity — its effects come from receptor activation rather than from flooding the brain with dopamine or serotonin.
Source: peer-reviewed pharmacology literature
Effects
2C-I is reported to produce visual enhancement and distortions, colour and pattern intensification, emotional openness, and a psychedelic headspace, generally described as milder and somewhat more stimulating than a classic strong psychedelic, and shorter and gentler than 2C-E. As with other 2C compounds a physical "body load" — restlessness, nausea, or muscle tension — can accompany the experience. Effects are taken orally and build over the course of an experience lasting several hours.
Source: Shulgin (PiHKAL); peer-reviewed pharmacology literature
Risks & harms
The most important safety point with 2C-I is the risk of confusion with 25I-NBOMe ("Smiles"), a different and much more toxic drug that has caused deaths and is sometimes sold as 2C-I; material sold under either name cannot be assumed to be what it claims. 2C-I itself can cause a raised heart rate and blood pressure, agitation, anxiety, nausea, and frightening psychological experiences, particularly at higher doses. Like 2C-E it is metabolized by monoamine oxidase (MAO) enzymes, so combining it with an MAO inhibitor can dangerously intensify its effects. Because purity and identity of powders vary, and because dose response differs between the 2C compounds, taking an unknown "2C" without confirmation of what it actually is carries real risk.
Source: peer-reviewed pharmacology literature
Subjective effects
LSD-like hallucinations/visual distortion + MDMA-like empathy
Onset
delayed (redose-risk)
Duration
up to 8 hr
Harmful effects
accidental overdose from delayed onset → redosing; sold misrepresented as MDMA/LSD
Medicinal use
none
Prevalence
NFLIS 633 reports since 2003 (peak 95 in 2011–12; <5/yr 2023–25)
Legal status (US)
Schedule I
Source: US federal law
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling, because penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With psychedelics, fear and confusion are usually temporary. Change your surroundings, calmer light, quiet music, a trusted person, and remind yourself it will lift as the drug wears off.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown, pending review”Identity
- PubChem CID
- 10267191PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 2-(4-iodo-2,5-dimethoxyphenyl)ethanaminePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C10H14INO2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- COC1=CC(=C(C=C1CCN)OC)IPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- PQHQBRJAAZQXHL-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- smiles, 2C-I compound, DEA No. 7518PubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown, pending review
Effects, risks & interactions
- Effects
- 2C-I is a serotonin 5-HT2A receptor agonist that produces the visual and perceptual changes, stimulation and altered mood typical of its family. As with the rest of the class, it appeared as an unregulated "research chemical," and controlled human data are sparse; descriptions of its effects and potency come largely from uncontrolled use rather than clinical study, so they should be read as uncertain.PubChem CID 10267191 + NIDA Hallucinogens ↗ · retrieved 2026-06-18
- Risks
- The defining hazard of 2C-I is confusion with 25I-NBOMe — a chemically related but far more potent and dangerous compound sometimes mis-sold under the "2C-I" name or as a psychedelic. NIDA notes that NBOMe compounds are highly potent and have caused severe toxicity, so a buyer expecting 2C-I who actually receives an NBOMe faces serious danger, and the two cannot be told apart without laboratory testing. Its own physical effects, so far as they are known, can include restlessness, a fast or pounding heartbeat, elevated blood pressure and overheating. Because supply is unregulated and identity uncertain, the contents and strength of anything sold as 2C-I cannot be assumed.PubChem CID 10267191 + NIDA Hallucinogens ↗ · retrieved 2026-06-18
- Interactions
- Unknown, pending review
Dosage
Pending medical reviewer
